Tirzepatide Oral Suspension

Description

Tirzepatide is a medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Both GIP and GLP-1 are hormones involved in regulating insulin secretion, appetite, and energy balance. By targeting both receptors, Tirzepatide may offer enhanced effects on blood glucose control and weight loss compared to GLP-1 receptor agonists alone.

As with other drugs in this class, the most common side effects of Tirzepatide are gastrointestinal in nature, including nausea, vomiting, diarrhea, and constipation. These side effects are usually dose-dependent and tend to decrease over time.

Tirzepatide should be used in conjunction with a reduced-calorie diet and increased physical activity. It should not be used in combination with other GLP-1 receptor agonists or drugs that contain Tirzepatide.